TY - JOUR T1 - Smoking and interstitial lung diseases JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 428 LP - 435 DO - 10.1183/16000617.0050-2015 VL - 24 IS - 137 AU - George A. Margaritopoulos AU - Eirini Vasarmidi AU - Joseph Jacob AU - Athol U. Wells AU - Katerina M. Antoniou Y1 - 2015/09/01 UR - http://err.ersjournals.com/content/24/137/428.abstract N2 - For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases. In the recent years, attention has also focused on the role of smoking in the development of interstitial lung diseases (ILDs). Indeed, there are three diseases, namely respiratory bronchiolitis-associated ILD, desquamative interstitial pneumonia and pulmonary Langerhans cell histiocytosis, that are currently considered aetiologically linked to smoking and a few others which are more likely to develop in smokers. Here, we aim to focus on the most recent findings regarding the role of smoking in the pathogenesis and clinical behaviour of ILDs.Smoking is implicated in the pathogenesis and clinical behaviour of interstitial lung disease http://ow.ly/PYLcT ER -